Document And Entity Information |
Jun. 03, 2026 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Document Period End Date | Jun. 03, 2026 |
| Entity Registrant Name | AVITA Medical, Inc. |
| Entity Central Index Key | 0001762303 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-39059 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 85-1021707 |
| Entity Address, Address Line One | 28159 Avenue Stanford |
| Entity Address, Address Line Two | Suite 220 |
| Entity Address, City or Town | Valencia |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 91355 |
| City Area Code | 661 |
| Local Phone Number | 367-9170 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | RCEL |
| Security Exchange Name | NASDAQ |
| Amendment Description | This Current Report on Form 8-K/A (this "Amendment") amends the Current Report on Form 8-K filed by AVITA Medical, Inc. (the "Company") with the Securities and Exchange Commission on June 4, 2026 (the "Original Form 8-K"), which reported, among other things, the voting results of the Company's Annual Meeting of Stockholders held on June 3, 2026 (the "Meeting"). The sole purpose of this Amendment is to disclose, in accordance with Item 5.07(d) of Form 8-K, the Company’s decision regarding how frequently it will conduct future stockholder advisory votes to approve the compensation of the Company’s named executive officers. No other changes have been made to the Original Form 8-K. |